Large language models (LLMs) and generative AI are rapidly changing the healthcare industry. These technologies have the potential to revolutionize healthcare by improving the efficiency, accuracy, and personalization of care. This practical book shows healthcare leaders, researchers, data scientists, and AI engineers the potential of LLMs and generative AI today and in the future, using storytelling and illustrative use cases in healthcare.

Authors Kerrie Holley, former Google healthcare professionals, guide you through the transformative potential of large language models (LLMs) and generative AI in healthcare. From personalized patient care and clinical decision support to drug discovery and public health applications, this comprehensive exploration covers real-world uses and future possibilities of LLMs and generative AI in healthcare.

With this book, you will:

• • Understand the promise and challenges of LLMs in healthcare • Learn the inner workings of LLMs and generative AI • Explore automation of healthcare use cases for improved operations and patient care using LLMs • Dive into patient experiences and clinical decision-making using generative AI • Review future applications in pharmaceutical R&D, public health, and genomics • Understand ethical considerations and responsible development of LLMs in healthcare

"The authors illustrate generative's impact on drug development, presenting real-world examples of its ability to accelerate processes and improve outcomes across the pharmaceutical industry." --Harsh Pandey, VP, Data Analytics & Business Insights, Medidata-Dassault

Kerrie Holley is a retired Google tech executive, IBM Fellow, and VP/CTO at Cisco. Holley's extensive experience includes serving as the first Technology Fellow at United Health Group (UHG), Optum, where he focused on advancing and applying AI, deep learning, and natural language processing in healthcare.

Manish Mathur brings over two decades of expertise at the crossroads of healthcare and technology. A former executive at Google and Johnson & Johnson, he now serves as an independent consultant and advisor. He guides payers, providers, and life sciences companies in crafting cutting-edge healthcare solutions.